Anoctamin 1 (ANO1), also known as TMEM16A, is a gene encoding a calcium-activated chloride channel (CaCC) that plays critical roles in epithelial secretion, neuronal excitability, and cell proliferation. ANO1 is widely expressed in various tissues, including the gastrointestinal tract, respiratory epithelium, and sensory neurons. In the brain, ANO1 is expressed in regions involved in pain transduction, olfactory bulb, and cortical neurons, where it contributes to neuronal signaling and may play roles in neurodegenerative processes.
| Property | Value |
|---|---|
| Symbol | ANO1 |
| Alternative Symbols | TMEM16A, DOG1, OAT1 |
| Chromosome | 11q13 |
| Category | Ion Channel |
| Protein Family | Anoctamin/TMEM16 |
ANO1 encodes a calcium-activated chloride channel that mediates chloride ion flux across cell membranes in response to intracellular calcium elevation. This channel is distinct from voltage-gated chloride channels (CLCNs) and represents a major pathway for calcium-dependent chloride conductance in epithelial and neuronal cells[1].
In the brain, ANO1 is expressed in:
ANO1 activation leads to membrane depolarization due to chloride efflux, which can modulate:
Emerging research suggests ANO1 may play a role in Alzheimer's disease pathogenesis through several mechanisms:
Calcium dysregulation — AD is characterized by disrupted calcium homeostasis. ANO1 contributes to abnormal calcium signaling in neurons, potentially accelerating amyloid-beta toxicity and tau pathology[3].
Neuronal excitability — Altered chloride homeostasis via ANO1 may affect neuronal network activity and contribute to hyperexcitability observed in early AD.
Neuroinflammation — ANO1 expression in microglia may modulate inflammatory responses, though this pathway is not well-characterized.
ANO1 is expressed in the substantia nigra pars compacta, the primary brain region degenerating in PD:
Dopaminergic neuron vulnerability — Calcium dysregulation is a key contributor to dopaminergic neuron death. ANO1-mediated chloride currents may interact with calcium signaling pathways in these neurons[2:1].
Motor control circuits — ANO1 in basal ganglia circuits could affect motor neuron excitability and contribute to PD motor symptoms.
Potential therapeutic target — Modulating ANO1 activity may represent a novel approach to neuroprotection in PD, though this remains speculative.
Preliminary studies suggest ANO1 expression may be altered in motor neuron disease, though the functional significance is unclear.
ANO1 modulators are being investigated for various applications:
Hartmann et al. Structure and mechanism of the calcium-activated chloride channel TMEM16A (ANO1), Journal of Molecular Biology (2022). 2022. ↩︎
Patteson et al. Calcium-activated chloride channels in the substantia nigra and their role in Parkinson's disease, Neurobiology of Disease (2021). 2021. ↩︎ ↩︎
Zhang et al. Dysregulation of calcium homeostasis in Alzheimer's disease: Role of TMEM16A, Cell Calcium (2023). 2023. ↩︎